Skip to main content

Table 8 The cumulative ten years cost - effectiveness and cost – benefit of sif in montreal using the Jacobs et al.[18] model

From: A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada

Variables Annual cost of operation # of HIV averted # of HCV averted Cost-effectiveness ratio HCV Cost-effectiveness ratio HIV Cost-benefit ratio HCV Cost-benefit ratio HIV
Post SIF $21,828,000 140 840 $25,986 $155,914 1.35 1.35
Two SIF $43,656,000 260 1620 $26,948 $167,908 1.25 1.25
Three SIF $65,484,000 320 1950 $33,582 $204,637 1.03 1.03
Four SIF $87,312,000 370 2270 $38,463 $235,978 0.89 0.89
Five SIF $109,140,000 430 2610 $41,816 $253,814 0.83 0.83
Six SIF $130,968,000 480 2940 $44,547 $272,850 0.77 0.77
Seven SIF $152,796,000 530 3270 $46,727 $288,294 0.73 0.73
Average $87,312,000 360 2210 $39,508 $242,533 0.87 0.87